Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 13/20 | 0.50 |
| ▸ | ADRB3 | P13945 | 13/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 5/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | CASR | P41180 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7028696 | 0.88 | ADRB1 (0.50) | ADRB1ADRB3ADRB2ATMMEN1 | |
| SCHEMBL7027570 | 0.79 | ADRB1 (0.56) | ADRB1ADRB3ADRB2 | |
| SCHEMBL7027312 | 0.79 | MEN1 (0.65) | ADRB1ADRB3ADRB2ATMCASR | |
| SCHEMBL7021520 | 0.78 | ADRB1 (0.47) | ADRB1ADRB3ADRB2ATMCASR | |
| SCHEMBL7030630 | 0.76 | KDM4E (0.45) | ADRB1ADRB3ADRB2ATMCASR | |
| SCHEMBL7023578 | 0.75 | ADRB1 (0.50) | ADRB1ADRB3ADRB2ATMCASR | |
| SCHEMBL7608531 | 0.75 | ADRB1 (0.42) | ADRB1ADRB3ADRB2MEN1KMT2A | |
| SCHEMBL7032501 | 0.74 | ALDH1A1 (0.51) | ADRB1ADRB3ALDH1A1 | |
| SCHEMBL6327240 | 0.73 | MEN1 (0.70) | ADRB1ADRB3ADRB2ATMMEN1 | |
| SCHEMBL7033981 | 0.73 | MEN1 (0.70) | ADRB1ADRB3ADRB2ATMMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030032834-A1 | Aminoalcohol derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2003-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032834-A1 | Aminoalcohol derivatives | ADRB1, ADRB2, ADRB3 | ADRB1 1/4885ADRB3 3/4885ADRB2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.